NovaBridge Biosciences
NBP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$49,696 | -$208,177 | -$2,507,317 | -$2,331,541 |
| Dep. & Amort. | $978 | $1,063 | $63,816 | $34,136 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | -$1,949 | $10,261 | $357,148 | $608,609 |
| Change in WC | -$2,811 | -$37,202 | $552,064 | $394,520 |
| Other Non-Cash | $809 | $161,201 | $431,484 | $321,183 |
| Operating Cash Flow | -$52,669 | -$72,854 | -$1,102,805 | -$973,093 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$48 | -$164 | -$45,830 | -$29,932 |
| Net Acquisitions | $0 | $0 | $0 | -$6,000 |
| Inv. Purchases | -$245,863 | $0 | -$7,407,332 | -$10,173,314 |
| Inv. Sales/Matur. | $109,834 | $0 | $7,911,518 | $9,482,040 |
| Other Inv. Act. | $62 | -$107,467 | $26 | $0 |
| Investing Cash Flow | -$135,970 | -$107,631 | $458,382 | -$727,206 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $2,748 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$335 | -$8,663 | -$3,080 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $408 | $42,689 | $593,924 |
| Financing Cash Flow | -$335 | -$8,255 | $42,357 | $593,924 |
| Forex Effect | -$44,807 | $36,887 | $389,203 | -$128,771 |
| Net Chg. in Cash | -$233,763 | -$151,582 | -$212,863 | -$1,235,146 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $302,004 | $462,920 | $3,523,632 | $4,758,778 |
| End Cash | $68,240 | $311,338 | $3,310,769 | $3,523,632 |
| Free Cash Flow | -$52,717 | -$73,018 | -$1,148,635 | -$1,003,025 |